Skip to content
Centurion İlaç logo — Her hasta modern tedavi şansını ve yüksek yaşam kalitesini h...

Centurion İlaç

Her hasta modern tedavi şansını ve yüksek yaşam kalitesini hak eder…

Founded 1949 Turkey Turkey 219 employees Biotechnology, Pharmaceutical

General Information

Company Name Centurion İlaç
Founded Year 1949
Location Turkey Turkey
Employees 219
Industries Biotechnology, Pharmaceutical
Business Model B2B, B2C, D2C
Revenue Model Product Sales, Licensing, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Centurion İlaç. To contact Centurion İlaç, visit centurion.com.tr.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Centurion İlaç compare?

A PDF of Centurion İlaç and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Centurion İlaç soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Centurion İlaç

Centurion İlaç is a prominent player in the Biotechnology and Pharmaceutical industries, stemming from its deep roots since being founded in 1949. This Turkish company is noted for its extensive reach both domestically and internationally, with operations across over 15 countries. Its strong emphasis on advancing treatment options, specifically for Orphan disease, Plasma products, Hospital injectable, and Vaccines, establishes it as a key contributor to modern healthcare.

The establishment of its R&D Department in 2011 marks a pivotal shift towards the development and manufacturing of specialist-oriented products locally, reflecting a commitment to innovation in health solutions. Centurion’s core philosophy revolves around ensuring every patient has access to cutting-edge treatments, guided by their slogan: "Her hasta modern tedavi şansını ve yüksek yaşam kalitesini hak eder…” Despite its longstanding presence, the company has not disclosed recent investment activities.

Business keywords: Orphan Diseases, Plasma Products, Hospital Injectable, Vaccines, OTC Products, R&D in Pharmaceuticals, Specialist Oriented Products, Biosimilars, Pharmaceutical Manufacturing, High Quality of Life, Respect for Human Being, International Pharmaceutical Operations, Modern Treatment Alternatives, Innovative Pharmaceuticals, Healthcare Solutions

Services & Products

Development of Sterile Injectables
Research and Development in Pharmaceuticals
Therapeutic Solutions for Unmet Medical Needs
Collaboration with Pharmaceutical Companies
Advanced Manufacturing Technologies

Target Customers

Patients of All Age Groups Healthcare Providers Pharmaceutical Companies Medical Institutions

No funding data available for Centurion İlaç yet.

Centurion İlaç Alternatives & Competitors

View All Alternatives
Centurion İlaç vs
EUSA Pharma
EUSA Pharma United Kingdom

Part of Recordati Rare Diseases, the business unit dedicated to rare diseases in the Recordati group...

Venture round
107 employees
Biotechnology, Health Care
Centurion İlaç vs
Novartis
Novartis Switzerland

Reimagining medicine by transforming cancer

IPO
84734 employees
Biotechnology, Pharmaceutical
Centurion İlaç vs

This comprehensive guide captures the dynamic and intricate world of modern design and technology, o...

2011 employees
Biotechnology, Health Care

FAQ About Centurion İlaç

Her hasta modern tedavi şansını ve yüksek yaşam kalitesini hak eder…
Centurion İlaç was founded in 1949.
Centurion İlaç is headquartered in Turkey.
Centurion İlaç operates in Biotechnology and Pharmaceutical. Its work centres on Orphan Diseases, Plasma Products, Hospital Injectable and Vaccines. Its customers include Patients of All Age Groups, Healthcare Providers and Pharmaceutical Companies.
Centurion İlaç has a B2B, B2C and D2C business model. Its revenue comes from Product Sales, Licensing and Service Fee.
Centurion İlaç has approximately 219 employees.
Centurion İlaç offers: Development of Sterile Injectables, Research and Development in Pharmaceuticals, Therapeutic Solutions for Unmet Medical Needs, Collaboration with Pharmaceutical Companies, Advanced Manufacturing Technologies.
Top alternatives and competitors to Centurion İlaç include EUSA Pharma, Novartis, Bilim İlaç, Daiichi Sankyo Japan, dianosic. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Centurion İlaç and EUSA Pharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Centurion İlaç, https://bouncewatch.com/company/centurion, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout